Flu Vaccines and Associated Supplies

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATL GEOSPATIAL-INTELLIGENCE AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HM047626Q0030

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Springfield, Virginia, UNITED STATES

SourceSAM
Documents5
The National Geospatial-Intelligence Agency (NGA), a component of the U.S. Department of Defense, has issued a combined synopsis/solicitation (Procurement Identifier: HM047626Q0030) for the provision of flu vaccines and associated supplies. This procurement seeks to secure a reliable source for the manufacturing and delivery of pharmaceutical preparations, specifically influenza vaccines, to support the health and readiness of NGA personnel at its Springfield, Virginia location. The scope of this solicitation encompasses the supply of flu vaccines along with any necessary ancillary supplies required for their administration. Contractors are expected to review the full solicitation document and the accompanying Statement of Work (SOW) to ensure a comprehensive understanding of the technical and logistical requirements. The intended outcome is to establish a single contract with a responsible offeror whose proposal meets all solicitation criteria and offers the lowest price while remaining technically acceptable (LPTA). Key requirements include adherence to the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and compliance with the Product Service Code (PSC) 6505, covering drugs and biologicals. Offerors must ensure that their products and services align with these classifications and the specific needs outlined in the SOW. Notably, Amendment 0001 to the solicitation has removed the total small business set-aside provision (FAR 52.219-6), thereby opening the competition to a broader range of qualified vendors. The amendment also provides government responses to vendor questions (available in the attached Q&A) and extends the proposal submission deadline to 5:00pm Central Time on August 10, 2026. All other solicitation requirements remain unchanged. The contract will be awarded based on the LPTA evaluation method, ensuring that the selected vendor not only offers competitive pricing but also meets all technical specifications and quality standards as defined by the NGA. Interested parties are required to complete the attached quote sheet and submit their proposals in accordance with the revised timeline. The place of performance for this contract is Springfield, Virginia, and all deliverables must be provided to this location as specified in the solicitation documents. The primary point of contact for this procurement is Kathleen Dee, who can be reached at [email protected] or by phone at 314-676-1268 for any questions or clarifications regarding the solicitation. This opportunity remains active and is posted on SAM.gov under Opportunity ID 76ac213da74943198dd5f37f6da337ab. Contractors are encouraged to review all attachments and ensure compliance with the stated requirements before submitting their proposals. In summary, this procurement represents a significant opportunity for qualified pharmaceutical manufacturers and suppliers to support the NGA’s mission by providing essential flu vaccines and related supplies, with a clear focus on technical compliance, cost-effectiveness, and timely delivery to the Springfield, VA facility.